Exelixis

Exelixis and Genentech hammer out new deal terms
Exelixis and Genentech hammer out new deal terms
BioPharma Dive
Exelixis
Genentech
Cotellic
melanoma
Flag link:
Exelixis & Bristol-Myers Initiate Trial on Opdivo-Cabometyx
Exelixis & Bristol-Myers Initiate Trial on Opdivo-Cabometyx
Yahoo/Zacks.com
Exelixis
Bristol-Myers Squibb
clinical trials
Opdivo
Opdivo-Cabometyx
renal cell carcinoma
Flag link:
3 Mid-Cap Biotech Stocks That May Be Red-Hot Takeover Candidates
3 Mid-Cap Biotech Stocks That May Be Red-Hot Takeover Candidates
Motley Fool
biotech
M&A
Exelixis
Portola Pharmaceuticals
Intercept Pharmaceuticals
Flag link:
Exelixis clears debt, turning eye to future growth
Exelixis clears debt, turning eye to future growth
BioPharma Dive
debt
Exelixis
Flag link:
Exelixis, Inc. Turns a Profit, but Don't Get Too Excited
Exelixis, Inc. Turns a Profit, but Don't Get Too Excited
Motley Fool
Exelixis
earnings
Flag link:
2 Big Reasons Exelixis, Inc. Soared 22% in January
2 Big Reasons Exelixis, Inc. Soared 22% in January
Motley Fool
Exelixis
Cotellic
Roche
cabozantinib
Takeda
Flag link:
On a deal spree, Takeda grabs Japanese cabo rights in $145M pact with Exelixis
On a deal spree, Takeda grabs Japanese cabo rights in $145M pact with Exelixis
Endpoints
Takeda
Japan
cabozantinib
Exelixis
Flag link:
Biotech Stocks: What to Watch in 2017
Biotech Stocks: What to Watch in 2017
Motley Fool
biotech
Seattle Genetics
Exelixis
Clovis Oncology
Kite Pharma
Flag link:
The Best Biopharma CEOs of 2016 Are...
The Best Biopharma CEOs of 2016 Are...
TheStreet.com
Pharma CEOs
Ken Frazier
Merck
David Hung
Medivation
Scott Jackson
Celator Pharmaceuticals
Ed Kaye
Sarepta Therapeutics
Mike Morrissey
Exelixis
Flag link:
The 5 Best Biotech Stocks of 2016
The 5 Best Biotech Stocks of 2016
Motley Fool
biotech
biotech stocks
AXIM Biotech
CoLucid Pharmaceuticals
Corbus
Exelixis
Tesarao
Flag link:
What's Pfizer's Excuse for Not Buying Exelixis?
What's Pfizer's Excuse for Not Buying Exelixis?
Motley Fool
Pfizer
Exelixis
M&A
Cabometyx
kidney cancer
Sutent
Flag link:
3 Things Exelixis Must Do to Survive and Thrive in 2017
3 Things Exelixis Must Do to Survive and Thrive in 2017
Motley Fool
Exelixis
cabozantinib
Cabometyx
Cometriq
Flag link:
5 Reasons Exelixis's Cabometyx Is Set To Be The Next Blockbuster Opportunity
5 Reasons Exelixis's Cabometyx Is Set To Be The Next Blockbuster Opportunity
Seeking Alpha
Exelixis
Cabometyx
renal cell carcinoma
Flag link:
Exelixis reports 3Q loss
Exelixis reports 3Q loss
Yahoo/AP
earnings
Exelixis
Flag link:
Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis
Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis
Motley Fool
Pfizer
Bristol-Myers Squibb
Exelixis
Cabometyx
kidney cancer
Sutent
Opdivo
Flag link:
These 3 Little Biotechs Just Scored Big
These 3 Little Biotechs Just Scored Big
Motley Fool
biotech
Celldex Therapeutics
melanoma
glemba
Exelixis
Cabometyx
renal cell carcinoma
Tesaro
ovarian cancer
niraparib
Flag link:
Exelixis and Pfizer drugs compete in kidney cancer trial
Exelixis and Pfizer drugs compete in kidney cancer trial
Yahoo/Reuters
kidney cancer
Exelixis
Pfizer
Sutent
Cabometyx
Flag link:
Key FDA Decisions and Trial Results Expected in October
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
FDA
clinical trials
Exelixis
cabozantinib
Cobimetinib
Celldex Therapeutics
CDX-011
Cerulean Pharma
CRLX101
Medivation
Xtandi
Palatin
bermelanotide
Rexahn
RX-3117
Anthera Pharmaceuticals
Flag link:
Key FDA Decisions and Trial Results Coming in the Next 2 Months
Key FDA Decisions and Trial Results Coming in the Next 2 Months
24/7 Wall St
FDA
clinical trials
Array Biopharma
binimetinib
Mast Therapeutics
Novavax
RSV F vaccine
Threshold Pharmaceuticals
tarloxotinib
Cerulean Pharma
Vertex Pharmaceuticals
Orkambi
Exelixis
cabozantinib
Cobimetinib
Medivation
Xtandi
Celldex
Flag link:
Key FDA Decisions and Trial Results Expected in October
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
FDA
clinical trials
cabozantinib
Cobimetinib
Exelixis
Medivation
Xtandi
Celldex Therapeutics
glemba
Palatin
bremelanotide
CRLX101
Cerulean Pharma
Anthera Pharmaceuticals
Flag link: